News

Arena Pharmaceuticals has disclosed results from the Behavioral modification and Lorcaserin second study for obesity management trial (BLOSSOM). BLOSSOM confirms the results previously reported for the Behavioral modification

Millennium has announced that the FDA has granted priority review to the company’s supplemental new drug application (sNDA) for VELCADE. The sNDA contains long-term overall survival (OS) data

California Stem Cell (CSC) and Stemina Biomarker Discovery have announced that the study using CSC’s 96-well CardioPlate containing high purity human embryonic stem cell (hESC)-derived cardiomyocyte progenitor cells,

Teijin, a fine chemical company, has announced that it has begun producing its proprietary heat-resistant bioplastic BIOFRONT at a demonstration plant in Matsuyama, Ehime Prefecture. The plant was

Dey has settled a lawsuit brought against it and other companies by the State of Utah in October 2005 pertaining to Medicaid reimbursements paid by the state to

INEOS NOVA is planing to close the polystyrene (PS) plant at Breda, Netherlands. The plant has a capacity of 90,000 tonne/year with 50 employees. The company said that

Arkema has announced the construction of a carbon nanotube (CNT) pilot production plant at its Mont site (France, Pyrenees-Atlantiques). The 400ton/year plant, scheduled for startup in the beginning

Wound Management Technologies has completed the acquisition of BioPharma Management Technologies, a privately held biotechnology company with a platform of proprietary and patented technologies for topical pain management

Edifecs has extended its Edifecs5010 Compliance Suite offering by adding the new Edifecs5010 Comparison Manual, an analysis resource that provides side-by-side comparisons of the 4010A1 and 5010 HIPAA